Portal de Periódicos da CAPES

HTLV infection among foreign pregnant women living in Spain

2011; Elsevier BV; Volume: 52; Issue: 2 Linguagem: Inglês

10.1016/j.jcv.2011.06.010

1873-5967

Ana Treviño, Rafael Benito, Estrella Caballero, José Manuel Ramos, Patricia Parra, Lourdes Roc, José María Eirós Bouza, Antonio Aguilera, Juan González‐García, Carmen Luna, Goitzane Marcaida, Carmen Rodríguez, Matilde Trigo, Luis Alberto Rodríguez Arroyo, Carmen de Mendoza, Raúl Ortíz de Lejarazu, Vincent Soriano,

T-cell and Retrovirus Studies

The overall seroprevalence of HTLV infection among pregnant women in Spain is below 0.02% and accordingly universal antenatal screening is not recommended. However, as the number of immigrants has significantly increased during the last decade, this population might warrant specific considerations. To evaluate the seroprevalence of HTLV infection among immigrant pregnant women living in Spain. From January 2009 to December 2010 a cross-sectional study was carried out in all foreign pregnant women attended at 14 Spanish clinics. All were tested for HTLV antibodies using a commercial enzyme-immunoassay, being reactive samples confirmed by Western blot or PCR. A total of 3337 foreign pregnant women were examined. Their origin was as follows: Latin America 1579 (47%), North Africa 507 (16%), East Europe 606 (18%), Sub-Saharan Africa 316 (9%), North America and West Europe 116 (3.5%) and Asia and Australia 163 (5%). A total of 7 samples were confirmed as HTLV positive, of which 6 were HTLV-1 and 1 HTLV-2. HTLV-1 infection was found in 5 women coming from Latin America and 1 from Morocco. The only woman with HTLV-2 came from Ghana. The overall HTLV seroprevalence was 0.2%, being 0.3% among Latin Americans and 0.2% among Africans. It was absent among women coming from other regions. The seroprevalence of HTLV infection among foreign pregnant women in Spain is 0.2%, being all cases found in immigrants from Latin America and Africa. Given the benefit of preventing vertical transmission, antenatal screening should be recommended in pregnant women coming from these regions.